investment 564 - N/A N/A Doubtful debts (reversal) 508 -1 508 -92825% Loss on impairment of investments 11 - N/A N/A EBIT before share of profit from investment in associates and joint venture 237 1,405 -1,168
The Company’s operating result for the 1st half year of 2020, the company has revenue from sales Baht 616.5 million, decrease from the same period of last year at 29.4%. Gross profit margin is equal to
(Solaris) decreased. The Company recognized share of profit from associated companies under equity method decreased of Baht 69.74 million due to:- - The Company recognized share of profit from operating
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
its subsidiaries financial statement for Year 2017 end as of December 31, 2017, which details are as following; Results Year 2017 Year 2016 Increase (Decrease) Million Baht Million Baht Million Baht
company and its subsidiaries financial statement for Year 2017 end as of December 31, 2017, which details are as following; Results Year 2017 Year 2016 Increase (Decrease) Million Baht Million Baht Million
: Overall operating results for the six-month period ended June 30, 2019 and June 30, 2018 (Unit: Thousand Baht) Consolidated Financial Statements Separate Financial Statements Increase (Decrease) Q2/2019 Q2
49.34 17.69% Finance cost 49.11 68.10 18.99 38.67% Income tax expenses 48.04 57.52 9.48 19.73% Net profit 181.71 202.58 20.87 11.49% Net profit ratio (ROS) 17.16% 15.74% Earnings per share (Baht) 0.34
growing less than expected and moreover Thai foreign exchange rate of the Baht was appreciate that cause Financial Institutions Policy Committee announce to decrease the policy rate to 1.25% per year that
67.37 94.72 27.35 40.60% Income tax expenses 59.19 65.40 6.21 10.49% Net profit 227.68 252.81 25.13 11.04% Net profit ratio (ROS) 16.00% 14.78% Earnings per share (Baht) 0.37 0.42 0.05 13.51% Total